Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
10.55041/IJSREM36200
Volume:
8 |
7 |
Jul 2024
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
The Chinese city of Wuhan served as the focal point for the discovery of COVID-19, a zoonotic illness that would eventually spread around the world, in the start of 2020. Even though COVID-19 has a unique way of spreading and is quite strong, it shares resemblances to other zoonotic illnesses like SARS -CoV and MERS, among others, in that it produces acute respiratory distress and exhibits severe flu-like symptoms. The COVID-19 virus was dubbed SARS-CoV-2 due to a number of molecular similarities that have been found between it and SARS. These similarities have created a number of opportunities for COVID-19 patients to receive therapeutic treatments that have been proven successful in treating SARS. Potential for repurposing medications that have been effective in treating SARS has also been offered by the identification of commonalities between SARS-CoV and SARS-CoV-2 in terms of how they interact with the host, multiply, and cause life-threatening diseases. The article starts by providing a synopsis of COVID-19’s genesis in relation to other zoonotic illnesses, namely SARS and MERS. Even at the molecular level, a number of similarities between SARS and COVID-19 have been found. These similarities have led to the COVID-19 virus being dubbed SARS-CoV-2. These similarities have opened up a number of options for treating COVID-19 patients with therapeutic techniques that have been successful in treating SARS.It is important to note that the discovery of parallels between SARS-CoV and SARS-CoV-2 in terms of how they infiltrate the host, multiply, and produce potentially fatal illnesses has made it possible to repurpose medications that have been shown to be successful against SARS.
KEYWORDS
Publication Date
2/6/2024
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
0
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...